AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

Jeremy Walsh, who was recently named as the FDA's first-ever AI officer, has reportedly led the discussions with OpenAI, but so far, "no contract has been signed." 'Broader trend of AI adoption in ...